A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people Emily ReeveMagdalene OngDanijela Gnjidic Review 30 April 2017 Pages: 927 - 935
Patterns of drug prescriptions in an orthogeriatric ward as compared to orthopaedic ward: results from the Trondheim Hip Fracture Trial—a randomised clinical trial Marianne HeltneIngvild SaltvedtOlav Spigset Clinical Trial Open access 26 May 2017 Pages: 937 - 947
Anti-GPVI Fab SAR264565 effectively blocks GPVI function in ex vivo human platelets under arterial shear in a perfusion chamber Peter FlorianPeter WonerowJochen Graff Clinical Trial 18 May 2017 Pages: 949 - 956
The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries A. C. C. CostaE. B. CoelhoN. V. de Moraes Pharmacogenetics 14 April 2017 Pages: 957 - 963
Pharmacogenetic markers to predict the clinical response to methotrexate in south Indian Tamil patients with psoriasis S. IndhumathiMedha RajappaV. S. Negi Pharmacogenetics 25 April 2017 Pages: 965 - 971
The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients Nitsupa WattanachaiSutthida KaewmoongkunWichittra Tassaneeyakul Pharmacogenetics Open access 26 May 2017 Pages: 973 - 980
A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function Janna K. DuongM. Y. A. M. KroonenR. O. Day Pharmacokinetics and Disposition 28 April 2017 Pages: 981 - 990
Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol Iva MucaloMaja Ortner HadžiabdićVesna Bačić-Vrca Pharmacoepidemiology and Prescription 12 April 2017 Pages: 991 - 999
Patterns, predictors and persistence of chronic sedative use: a population-based observational study of older adults in British Columbia, Canada Steven G. MorganDeirdre Weymann Pharmacoepidemiology and Prescription 24 April 2017 Pages: 1001 - 1008
Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre? F KheloufiA DefaultJ Micallef Pharmacoepidemiology and Prescription 08 April 2017 Pages: 1009 - 1018
Correlation between proton pump inhibitors and risk of pyogenic liver abscess Hsien-Feng LinKuan-Fu LiaoShih-Wei Lai Pharmacoepidemiology and Prescription 22 April 2017 Pages: 1019 - 1025
Rational use of medicine in dentistry: do dentists prescribe antibiotics in appropriate indications? Cenker Z. KoyuncuogluMehtap AydinAhmet Akici Pharmacoepidemiology and Prescription 01 May 2017 Pages: 1027 - 1032
Chemotherapy-induced neutropenia as a prognostic factor in patients with metastatic pancreatic cancer treated with gemcitabine Aki OtakeDaiki TsujiKunihiko Itoh Pharmacoepidemiology and Prescription 09 May 2017 Pages: 1033 - 1039
Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication Ben SchöttkerKai-Uwe SaumHermann Brenner Pharmacoepidemiology and Prescription 24 May 2017 Pages: 1041 - 1048
Clincal interpretation of the anti-tuberculosis drug concentrations in diabetic and non-diabetic tuberculosis patients Nilan T Jacob Letter to the Editor 17 April 2017 Pages: 1049 - 1049
Amiodarone-induced thyroid dysfunction and a perturbed N-desethyl-amiodarone to amiodarone ratio: could a drug-induced toxicity be regulating exposure to the offending agent? Andrew RowlandAngela RowlandArduino A. Mangoni Letter to the Editor 03 May 2017 Pages: 1051 - 1052
Response: Amiodarone-induced thyroid dysfunction and a perturbed N-desethyl-amiodarone to amiodarone ratio; could a drug-induced toxicity be regulating exposure to the offending agent? Mitsutaka TakadaMikie YamatoAkira Oita Letter to the Editor 30 April 2017 Pages: 1053 - 1054